| | | | Market Reports
|
The Clinical Trials Market 2006
Published
The global clinical trials industry is currently worth an estimated $10 billion and has the potential for considerable growth in the future. Global revenues from clinical trials have increased by almost 15% in the last year and the industry is prepared for an extended period of healthy growth. Concern over safety and an extremely competitive pharmaceutical market has driven demand for large clinical trials but will also radically change how clinical trials are regulated and designed.
More>>
|
|
|
|
How to Succeed in Personalized Medicine by Using Tools and Technologies
Published January 2006
D&MD's How to Succeed in Personalized Medicine by Using Tools and Technologies market analysis report provides a clear understanding of the regulatory and commercial influences, elements shaping this growing market and offers an intensive investigation of pharmacogenomic business issues.
More>>
|
|
|
|
Organic and Medicinal Chemistry in Drug Discovery
Published October 2005
D&MD's Organic and Medicinal Chemistry in Drug Discovery market analysis report investigates the methods and technologies currently used to craft compound collections as well as the products and services available to support pharmaceutical chemistry programs.
More>>
|
|
|
|
Drug Targets from Genomics - Evolving Tools for Discovery
Published August 2005
Drug Targets from Genomics: Evolving Tools for Discovery seeks to examine the roles omic technologies play in pharma R&D, to assess their value to pharma, and to predict their future role and value. This Report analyzes current and projected revenues from sales of omic technology-based products (reagents and consumables), which in 2004 totaled nearly $1.5 billion.
More>>
|
|
|
|
Solving Drug Discovery with Metabolomics and Metabonomics
Published February 2005
There has been an 'omics' explosion. With the advent of genomics, proteomics, transcriptomics, there is also now metabolomics and metabonomics. These terms are the newest sibling to genomics and proteomics and are supposed to embody metabolic profiling.
More>>
|
|
|
| |
| |
|